Join a debate on whether dying patients should have access to experimental drugs, featuirng bioethicist Art Caplan of NYU Langone Medical Center and hosted by Pharmalot's Ed Silverman Monday at 8 p.m. ET on Twitter@pharmalot. #pharmalotchat
German companies are on a buying spree, and the U.S. is their biggest target. A flurry of U.S.-focused acquisitions this year has ramped up over the past week, including two on Monday, cementing Germany's ranking as the second-biggest foreign buyer of American companies this year.
GlaxoSmithKline and Avalon Ventures have launched three companies from their $495 million drug-discovery collaboration, giving each startup $10 million each over the next three years to pay for research readying potential drugs for testing in humans.